Global Sickle Cell Disease Treatments Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 1891

Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person's parents.
The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication.
In 2018, the global Sickle Cell Disease Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Sickle Cell Disease Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sickle Cell Disease Treatments development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird Bio
Global Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals

Market segment by Type, the product can be split into
Infection Prevention with Vaccination and Antibiotics
Blood Transfusion
The Medication Hydroxycarbamide
A Transplant of Bone Marrow Cells

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Sickle Cell Disease Treatments status, future forecast, growth opportunity, key market and key players.
To present the Sickle Cell Disease Treatments development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sickle Cell Disease Treatments are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sickle Cell Disease Treatments Market Size Growth Rate by Type (2014-2025)
1.4.2 Infection Prevention with Vaccination and Antibiotics
1.4.3 Blood Transfusion
1.4.4 The Medication Hydroxycarbamide
1.4.5 A Transplant of Bone Marrow Cells
1.5 Market by Application
1.5.1 Global Sickle Cell Disease Treatments Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Sickle Cell Disease Treatments Market Size
2.2 Sickle Cell Disease Treatments Growth Trends by Regions
2.2.1 Sickle Cell Disease Treatments Market Size by Regions (2014-2025)
2.2.2 Sickle Cell Disease Treatments Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Sickle Cell Disease Treatments Market Size by Manufacturers
3.1.1 Global Sickle Cell Disease Treatments Revenue by Manufacturers (2014-2019)
3.1.2 Global Sickle Cell Disease Treatments Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sickle Cell Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.2 Sickle Cell Disease Treatments Key Players Head office and Area Served
3.3 Key Players Sickle Cell Disease Treatments Product/Solution/Service
3.4 Date of Enter into Sickle Cell Disease Treatments Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Sickle Cell Disease Treatments Market Size by Type (2014-2019)
4.2 Global Sickle Cell Disease Treatments Market Size by Application (2014-2019)

5 United States
5.1 United States Sickle Cell Disease Treatments Market Size (2014-2019)
5.2 Sickle Cell Disease Treatments Key Players in United States
5.3 United States Sickle Cell Disease Treatments Market Size by Type
5.4 United States Sickle Cell Disease Treatments Market Size by Application

6 Europe
6.1 Europe Sickle Cell Disease Treatments Market Size (2014-2019)
6.2 Sickle Cell Disease Treatments Key Players in Europe
6.3 Europe Sickle Cell Disease Treatments Market Size by Type
6.4 Europe Sickle Cell Disease Treatments Market Size by Application

7 China
7.1 China Sickle Cell Disease Treatments Market Size (2014-2019)
7.2 Sickle Cell Disease Treatments Key Players in China
7.3 China Sickle Cell Disease Treatments Market Size by Type
7.4 China Sickle Cell Disease Treatments Market Size by Application

8 Japan
8.1 Japan Sickle Cell Disease Treatments Market Size (2014-2019)
8.2 Sickle Cell Disease Treatments Key Players in Japan
8.3 Japan Sickle Cell Disease Treatments Market Size by Type
8.4 Japan Sickle Cell Disease Treatments Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Sickle Cell Disease Treatments Market Size (2014-2019)
9.2 Sickle Cell Disease Treatments Key Players in Southeast Asia
9.3 Southeast Asia Sickle Cell Disease Treatments Market Size by Type
9.4 Southeast Asia Sickle Cell Disease Treatments Market Size by Application

10 India
10.1 India Sickle Cell Disease Treatments Market Size (2014-2019)
10.2 Sickle Cell Disease Treatments Key Players in India
10.3 India Sickle Cell Disease Treatments Market Size by Type
10.4 India Sickle Cell Disease Treatments Market Size by Application

11 Central & South America
11.1 Central & South America Sickle Cell Disease Treatments Market Size (2014-2019)
11.2 Sickle Cell Disease Treatments Key Players in Central & South America
11.3 Central & South America Sickle Cell Disease Treatments Market Size by Type
11.4 Central & South America Sickle Cell Disease Treatments Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sickle Cell Disease Treatments Introduction
12.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sickle Cell Disease Treatments Introduction
12.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sickle Cell Disease Treatments Introduction
12.3.4 Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sickle Cell Disease Treatments Introduction
12.4.4 Novartis Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sickle Cell Disease Treatments Introduction
12.5.4 Pfizer Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Baxter
12.6.1 Baxter Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sickle Cell Disease Treatments Introduction
12.6.4 Baxter Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.6.5 Baxter Recent Development
12.7 Emmaus Life Sciences
12.7.1 Emmaus Life Sciences Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sickle Cell Disease Treatments Introduction
12.7.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.7.5 Emmaus Life Sciences Recent Development
12.8 Bluebird Bio
12.8.1 Bluebird Bio Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sickle Cell Disease Treatments Introduction
12.8.4 Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.8.5 Bluebird Bio Recent Development
12.9 Global Blood Therapeutics
12.9.1 Global Blood Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sickle Cell Disease Treatments Introduction
12.9.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.9.5 Global Blood Therapeutics Recent Development
12.10 Sangamo Therapeutics
12.10.1 Sangamo Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sickle Cell Disease Treatments Introduction
12.10.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.10.5 Sangamo Therapeutics Recent Development
12.11 Acceleron Pharma
12.12 Arena Pharmaceuticals
12.13 Alnylam Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details